Head and neck squamous cell carcinoma

Keywords

MedicineHead and neck squamous-cell carcinomaCetuximabPembrolizumabLarynxOncologyNivolumabHead and neck cancerChemoradiotherapyInternal medicineRadiation therapyCancerCancer researchPathologyImmunotherapySurgeryColorectal cancer

Affiliated Institutions

Related Publications

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn , Shukui Qin , Masafumi Ikeda +18 more

In patients with unresectable hepatocellular carcinoma, atezolizumab combined with bevacizumab resulted in better overall and progression-free survival outcomes than sorafenib. ...

2020 New England Journal of Medicine 6464 citations

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer , Nizar M. Tannir , Ray McDermott +29 more

Overall survival and objective response rates were significantly higher with nivolumab plus ipilimumab than with sunitinib among intermediate- and poor-risk patients with previo...

2018 New England Journal of Medicine 4403 citations

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst , Paul Baas , Dong‐Wan Kim +16 more

2015 The Lancet 6378 citations

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

Rita Nanda , Laura Q.M. Chow , Elizabeth Claire Dees +9 more

Purpose Immune checkpoint inhibition has been demonstrated to be an effective anticancer strategy. Several lines of evidence support the study of immunotherapy in triple-negativ...

2016 Journal of Clinical Oncology 1427 citations

Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

Luis Paz‐Ares , Alexander Luft , David Vicente +20 more

In patients with previously untreated metastatic, squamous NSCLC, the addition of pembrolizumab to chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel resulted in si...

2018 New England Journal of Medicine 3472 citations

Publication Info

Year: 2020
Type: review
Volume: 6
Issue: 1
Pages: 92-92
Citations: 3577
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Head and neck squamous cell carcinoma

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

3577

OpenAlex

Cite This

APA Style

                            
                                
                                    Daniel E. Johnson, 
                                
                                    Barbara Burtness, 
                                
                                    C. René Leemans
                                
                                et al.
                            
                            (2020). 
                            Head and neck squamous cell carcinoma. 
                            Nature Reviews Disease Primers
                            , 6
                            (1)
                            , 92-92.
                            https://doi.org/10.1038/s41572-020-00224-3
                        

Identifiers

DOI: 10.1038/s41572-020-00224-3